“…Furthermore, many reports exist in which different forms of EDS have been associated with more or less well-characterized platelet or coagulation dysfunctions, including platelet aggregation dysfunction and prolonged bleeding time (Kashiwagi et al, 1965;Estes, 1968;Onel et al, 1973;Uden, 1982;Chouza et al, 1984;Anstey et al, 1991;Cunniff & Williamson-Kruse, 1995), platelet delta-storage pool disease (Espanol et al, 1998), deficiency of factor VIII (Clough et al, 1979;Bertin et al, 1989), factor IX (Gamba et al, 1986), factor XI (Anstey et al, 1991), factor XII (Fantl et al, 1961) and factor XIII (Anstey et al, 1991) and platelet sensitivity to aspirin (Grenko et al, 1993). These are, however, sporadic findings and are likely to be chance associations where the platelet or coagulation dysfunctions may have added to the bleeding tendency of an underlying EDS, thus prompting clinical investigation.…”